首页> 美国卫生研究院文献>Clinical Pediatric Endocrinology >A Novel Missense Mutation in the Thyroid Peroxidase Gene R175Q Resulting inInsufficient Cell Surface Enzyme in Two Siblings
【2h】

A Novel Missense Mutation in the Thyroid Peroxidase Gene R175Q Resulting inInsufficient Cell Surface Enzyme in Two Siblings

机译:甲状腺过氧化物酶基因R175Q的新型错义突变导致两个兄弟姐妹的细胞表面酶不足

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Thyroid peroxidase (TPO) abnormality is one of the causes of congenital hypothyroidism. Two missense mutations were found as a compound heterozygous mutation in two siblings with congenital goitrous hypothyroidism. One of these mutations, G614A (R175Q), was a novel mutation. Characterization of the novel mutation and a cotransfection experiment with two mutated TPO mRNAs were carried out. G614A-mRNA introduced into CHO-K1 cells expressed TPO protein with the same molecular weight as that of wild-type mRNA. The R175Q-TPO was thought to possess enzyme activity. In terms of localization, a very small amount of mutated TPO was expressed on the plasma membrane of CHO-K1 cells. This plasma membrane expression of R175Q-TPO was insufficient to perform thyroid hormone synthesis, but was markedly different from R665W-TPO. When G614A- and C2083T-mRNAs were cotransfected, cell surface TPO-positive cells were only 13.1% in contrast to 54.4% for wild-type mRNA. The low positivity and intensity of cell surface TPO suggested that in the patients’ thyroids thyroid hormone synthesis was hardly performed. The congenital hypothyroidism of the patients was thought to be a result of the mutations of the TPO gene (G614A/C2083T).
机译:甲状腺过氧化物酶(TPO)异常是先天性甲状腺功能低下的原因之一。在患有先天性甲状腺功能减退症的两个兄弟姐妹中,发现两个错义突变为复合杂合突变。这些突变之一G614A(R175Q)是一种新型突变。进行了新突变的表征,并进行了两个突变的TPO mRNA的共转染实验。导入CHO-K1细胞的G614A-mRNA表达的TPO蛋白分子量与野生型mRNA相同。 R175Q-TPO被认为具有酶活性。就定位而言,在CHO-K1细胞的质膜上表达了非常少量的突变的TPO。 R175Q-TPO的这种质膜表达不足以进行甲状腺激素合成,但与R665W-TPO明显不同。共转染G614A-和C2083T-mRNA时,细胞表面TPO阳性细胞仅为13.1%,而野生型mRNA为54.4%。细胞表面TPO的阳性和强度低表明在患者的甲状腺中几乎不进行甲状腺激素合成。患者的先天性甲状腺功能减退被认为是TPO基因(G614A / C2083T)突变的结果。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号